Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint Inhibitors

CONTEXT: Immune checkpoint inhibitors (ICIs) have gained a revolutionary role in management of many advanced malignancies. However, immune-related endocrine events (irEEs), have been associated with their use. irEEs have nonspecific clinical presentations and variable timelines, making their early d...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ashi, Suleiman I, Thapa, Bicky, Flores, Monica, Ahmed, Ramsha, Rahim, Shab E Gul, Amir, Maryam, Alomari, Mohammad, Chadalavada, Pravallika, Morrison, Shannon L, Bena, James F, Hercbergs, Aleck, Lashin, Ossama, Daw, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237848/
https://www.ncbi.nlm.nih.gov/pubmed/34195529
http://dx.doi.org/10.1210/jendso/bvab100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237848/
https://www.ncbi.nlm.nih.gov/pubmed/34195529
http://dx.doi.org/10.1210/jendso/bvab100

Ejemplares similares